RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies
2023-01-01 Bretto, Elisabetta; Ribaldone, Davide Giuseppe; Caviglia, Gian Paolo; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Frara, Simone
Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease
2021-01-01 Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi
Letter to the Editor: Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs?
2016-01-01 Vanni, E; Bugianesi, E; Saracco, G.M.
Liver cancer: Connections with obesity, fatty liver, and cirrhosis
2016-01-01 Marengo, Andrea; Rosso, Chiara; Bugianesi, Elisabetta
Management of non-alcoholic fatty liver disease
2021-01-01 Petroni M.L.; Brodosi L.; Bugianesi E.; Marchesini G.
Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
In corso di stampa Eslam, Mohammed; El-Serag, Hashem B; Francque, Sven; Sarin, Shiv K; Wei, Lai; Bugianesi, Elisabetta; George, Jacob
Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease
2023-01-01 Marta Guariglia, Francesca Saba, Chiara Rosso, Elisabetta Bugianesi
Molecular mechanisms of hepatic fibrosis in chronic liver diseases
2020-01-01 Rosso, Chiara; Caviglia, Gian Paolo; Younes, Ramy; Ribaldone, Davide G.; Fagoonee, Sharmila; Pellicano, Rinaldo; Bugianesi, Elisabetta
NAFLD and Hepatocellular Carcinoma: how big a problem is this really?
2014-01-01 E. Vanni; L. Mezzabotta; E. Bugianesi
NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes
2007-01-01 E. Bugianesi;E. Vanni;G. Marchesini
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inflammatory Bowel Disease: Emerging Therapies and Future Treatment Strategies | 2023 | Bretto, Elisabetta; Ribaldone, Davide Giuseppe; Caviglia, Gian Paolo; Saracco, Giorgio Maria; Bugianesi, Elisabetta; Frara, Simone | |
| Insulin Resistance across the Spectrum of Nonalcoholic Fatty Liver Disease | 2021 | Angelo Armandi, Chiara Rosso, Gian Paolo Caviglia, Elisabetta Bugianesi | |
| Letter to the Editor: Reply to "Chronic hepatitis C and diabetes: More questions than answers with the new direct acting antiviral drugs? | 2016 | Vanni, E; Bugianesi, E; Saracco, G.M. | |
| Liver cancer: Connections with obesity, fatty liver, and cirrhosis | 2016 | Marengo, Andrea; Rosso, Chiara; Bugianesi, Elisabetta | |
| Management of non-alcoholic fatty liver disease | 2021 | Petroni M.L.; Brodosi L.; Bugianesi E.; Marchesini G. | |
| Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight | In corso di stampa | Eslam, Mohammed; El-Serag, Hashem B; Francque, Sven; Sarin, Shiv K; Wei, Lai; Bugianesi, Elisabetta; George, Jacob | |
| Molecular Mechanisms of Curcumin in the Pathogenesis of Metabolic Dysfunction Associated Steatotic Liver Disease | 2023 | Marta Guariglia, Francesca Saba, Chiara Rosso, Elisabetta Bugianesi | |
| Molecular mechanisms of hepatic fibrosis in chronic liver diseases | 2020 | Rosso, Chiara; Caviglia, Gian Paolo; Younes, Ramy; Ribaldone, Davide G.; Fagoonee, Sharmila; Pellicano, Rinaldo; Bugianesi, Elisabetta | |
| NAFLD and Hepatocellular Carcinoma: how big a problem is this really? | 2014 | E. Vanni; L. Mezzabotta; E. Bugianesi | |
| NASH and the risk of cirrhosis and hepatocellular carcinoma in type 2 diabetes | 2007 | E. Bugianesi;E. Vanni;G. Marchesini |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 63
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 63
Data di pubblicazione
- In corso di stampa 1
- 2020 - 2024 33
- 2010 - 2019 28
- 2007 - 2009 1
Rivista
- DIGESTIVE AND LIVER DISEASE 6
- JOURNAL OF HEPATOLOGY 5
- HEPATOLOGY 3
- LIVER INTERNATIONAL 3
- MINERVA BIOTECNOLOGICA 3
- NATURE REVIEWS. GASTROENTEROLOGY ... 3
- CLINICS IN LIVER DISEASE 2
- CURRENT HEPATOLOGY REPORTS 2
- INTERNATIONAL JOURNAL OF MOLECULA... 2
- NATURE REVIEWS. GASTROENTEROLOGY ... 2
Keyword
- Humans 8
- Hepatology 7
- NAFLD 7
- Non-alcoholic Fatty Liver Disease 7
- insulin resistance 5
- Gastroenterology 4
- Steatohepatitis 4
- Biomarkers 3
- Cirrhosis 3
- Fatty liver 3
Lingua
- eng 56
- Inglese 5
- ita 2
Accesso al fulltext
- open 38
- partially open 10
- reserved 8
- no fulltext 5
- embargoed 2